tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Newitter, 345 are a BUY (57.5%), 253 are a HOLD (42.17%), 2 are a SELL (0.33%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 61.49% that have a potential upside of 22.71% achieved within 203 days.
Richard Newitter’s has documented 1,193 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNDM, Tandem Diabetes Care at 19-Mar-2026.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 11/24/2025. The price target of $128 was fulfilled within 1 day with a profit of $10.71 (9.13%) receiving and performance score of 91.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Jan-2026
$82
$8.35 (11.34%)
$80
14 days ago
(09-Mar-2026)
6/7 (85.71%)
$0.15 (0.18%)
106
Buy Since 08-Apr-2022
$100
$26.35 (35.78%)
$98
25 days ago
(26-Feb-2026)
15/29 (51.72%)
$15.87 (18.86%)
396
Hold Since 13-Oct-2025
$90
$16.35 (22.20%)
$86
25 days ago
(26-Feb-2026)
6/7 (85.71%)
$5.87 (6.98%)
599
Buy Since 19-Aug-2021
$92
$18.35 (24.92%)
$91
26 days ago
(25-Feb-2026)
8/13 (61.54%)
$7.87 (9.35%)
110
Buy Since 10-May-2023
$98
$24.35 (33.06%)
$95
4 months 10 days ago
(13-Nov-2025)
7/12 (58.33%)
$19.39 (24.67%)
285
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?
